We examined the hepatic expression of PGM5 in patients with liver cancer, determined its association with clinical parameters, calculated its diagnostic value using receiver operating characteristic (ROC) curves, and performed survival analysis and Cox modeling to evaluate its effect on prognosis. The gene discussed is PGM5; the disease is liver cancer.